StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Laboratorio Reig Jofre, S.A.
MCE:RJF.MC
Sector
Location
Market Cap
USD 289.24 M
Share Price
USD 3.52
Avg Daily Volume
37,113
Change (1 day)
-0.84%
Change (1 year)
20.87%
Change (YTD)
36.45%
Laboratorio Reig Jofre, S.A. Total Liabilities for the year ending December 31, 2024: USD 135.55 M
Laboratorio Reig Jofre, S.A. Total Liabilities is USD 135.55 M for the year ending December 31, 2024, a -2.76% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
-
Laboratorio Reig Jofre, S.A. Total Liabilities for the year ending December 31, 2023 was USD 139.40 M, a 5.97% change year over year.
-
Laboratorio Reig Jofre, S.A. Total Liabilities for the year ending December 31, 2022 was USD 131.54 M, a -15.32% change year over year.
-
Laboratorio Reig Jofre, S.A. Total Liabilities for the year ending December 31, 2021 was USD 155.34 M, a -4.15% change year over year.
-
Laboratorio Reig Jofre, S.A. Total Liabilities for the year ending December 31, 2020 was USD 162.07 M, a 6.60% change year over year.
Competitors
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
Johnson & Johnson
USD 155.92
JNJ
+3.17
2.08%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
McKesson Corporation
USD 727.74
MCK
-5.04
-0.69%
Elevance Health Inc.
USD 395.76
ELV
+6.80
1.75%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
Cencora, Inc.
USD 295.33
COR
-4.52
-1.51%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%
Lonza Group AG
USD 711.40
LONN.SW
-0.73
-0.10%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%
Key Data
| Date | Total Liabilities | Shareholders' Equity | Cash and Short-Term Investments | Receivables |
|---|
Competitors
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
Johnson & Johnson
USD 155.92
JNJ
+3.17
2.08%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
McKesson Corporation
USD 727.74
MCK
-5.04
-0.69%
Elevance Health Inc.
USD 395.76
ELV
+6.80
1.75%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
Cencora, Inc.
USD 295.33
COR
-4.52
-1.51%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%
Lonza Group AG
USD 711.40
LONN.SW
-0.73
-0.10%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%